#weight-loss-drugs

[ follow ]
#novo-nordisk
Startup companies
fromFast Company
1 week ago

Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers

Novo Nordisk's market outlook improves with FDA's ban on GLP-1 drug copycats.
Despite profit forecasts lowering, investor sentiment towards Novo Nordisk remains optimistic.
Startup companies
fromFast Company
4 days ago

Novo Nordisk announces CEO transition as share price slips

Novo Nordisk's CEO Lars Fruergaard Jorgensen is stepping down amid market challenges despite leading the company through significant growth in the weight-loss drug sector.
fromFast Company
4 months ago
Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

Startup companies
fromFast Company
1 week ago

Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers

Novo Nordisk's market outlook improves with FDA's ban on GLP-1 drug copycats.
Despite profit forecasts lowering, investor sentiment towards Novo Nordisk remains optimistic.
Startup companies
fromFast Company
4 days ago

Novo Nordisk announces CEO transition as share price slips

Novo Nordisk's CEO Lars Fruergaard Jorgensen is stepping down amid market challenges despite leading the company through significant growth in the weight-loss drug sector.
fromFast Company
4 months ago
Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

more#novo-nordisk
Alternative medicine
fromtime.com
1 week ago

Which Weight-Loss Drug Works the Best?

Zepbound shows superior weight loss compared to Wegovy in a recent clinical trial, influencing treatment decisions for obesity management.
#ozempic
OMG science
fromNature
1 month ago

Obesity-drug pioneers and 13,508 physicists win US$3-million Breakthrough Prizes

The scientists behind GLP-1 based weight-loss drugs Ozempic and Wegovy received a $3 million Breakthrough Prize for their life-saving contributions.
US news
fromwww.npr.org
5 months ago

Drugmakers and pharmacists battle over who gets to make obesity drugs

Demand for Ozempic and its alternatives has led to compounded versions, but brand manufacturers are actively trying to eliminate this competition.
Wearables
fromFuturism
1 week ago

Weight Watchers Goes Bankrupt After Rise of Ozempic-Like Drugs

Ozempic's popularity is reshaping the diet industry, severely affecting companies like Weight Watchers.
OMG science
fromNature
1 month ago

Obesity-drug pioneers and 13,508 physicists win US$3-million Breakthrough Prizes

The scientists behind GLP-1 based weight-loss drugs Ozempic and Wegovy received a $3 million Breakthrough Prize for their life-saving contributions.
US news
fromwww.npr.org
5 months ago

Drugmakers and pharmacists battle over who gets to make obesity drugs

Demand for Ozempic and its alternatives has led to compounded versions, but brand manufacturers are actively trying to eliminate this competition.
Wearables
fromFuturism
1 week ago

Weight Watchers Goes Bankrupt After Rise of Ozempic-Like Drugs

Ozempic's popularity is reshaping the diet industry, severely affecting companies like Weight Watchers.
more#ozempic
#healthcare
Healthcare
fromBusiness Insider
2 months ago

New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.

Weight-loss drugs are expensive due to the high development costs and the limited time to recoup investment before patents expire.
Healthcare
fromBusiness Insider
2 months ago

New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.

Weight-loss drugs are expensive due to the high development costs and the limited time to recoup investment before patents expire.
more#healthcare
#fda
Growth hacking
from24/7 Wall St.
2 months ago

HIMS Stock Craters - Is It a Buying Opportunity?

Hims & Hers Health faces challenges after the FDA resolved the semaglutide shortage, impacting their growth from compounding drug sales.
Growth hacking
from24/7 Wall St.
2 months ago

HIMS Stock Craters - Is It a Buying Opportunity?

Hims & Hers Health faces challenges after the FDA resolved the semaglutide shortage, impacting their growth from compounding drug sales.
more#fda
#obesity-treatment
Healthcare
fromwww.mercurynews.com
2 months ago

Patients struggle with lack of consistent coverage for popular weight-loss drugs

Access to obesity treatments is hindered by inconsistent insurance coverage and high costs, making it difficult for many to maintain weight loss.
Medicine
fromtime.com
1 month ago

Medicare Will Not Cover GLP-1 Drugs for Weight Loss

Medicare and Medicaid will not cover weight-loss drugs for obesity treatment, affecting millions.
Healthcare
fromwww.mercurynews.com
2 months ago

Patients struggle with lack of consistent coverage for popular weight-loss drugs

Access to obesity treatments is hindered by inconsistent insurance coverage and high costs, making it difficult for many to maintain weight loss.
Medicine
fromtime.com
1 month ago

Medicare Will Not Cover GLP-1 Drugs for Weight Loss

Medicare and Medicaid will not cover weight-loss drugs for obesity treatment, affecting millions.
more#obesity-treatment
#zepbound
Wearables
fromwww.nytimes.com
2 months ago

How Much Should Weight Loss Drugs Like Wegovy and Zepbound Cost?

The cost of weight loss drugs Wegovy and Zepbound outweighs their health benefits, as per a study from the University of Chicago.
US news
fromwww.npr.org
4 months ago

FDA approves weight loss drug Zepbound to treat obstructive sleep apnea

Zepbound is the first FDA-approved drug for treating sleep apnea linked to obesity.
The drug aids in weight loss, which alleviates sleep apnea symptoms effectively.
fromBusiness Insider
8 months ago
Medicine

Eli Lilly just halved the price of its weight-loss drug - declaring war on the booming market of knock-offs

Eli Lilly is significantly reducing the price of Zepbound to $399-$549 to combat counterfeits and enhance patient access.
fromFast Company
8 months ago
Medicine

Eli Lilly just made its weight-loss drug cheaper with a simple design tweak

Eli Lilly's new Zepbound vials improve drug access and affordability despite increased user difficulty compared to autoinjector pens.
Wearables
fromwww.nytimes.com
2 months ago

How Much Should Weight Loss Drugs Like Wegovy and Zepbound Cost?

The cost of weight loss drugs Wegovy and Zepbound outweighs their health benefits, as per a study from the University of Chicago.
US news
fromwww.npr.org
4 months ago

FDA approves weight loss drug Zepbound to treat obstructive sleep apnea

Zepbound is the first FDA-approved drug for treating sleep apnea linked to obesity.
The drug aids in weight loss, which alleviates sleep apnea symptoms effectively.
more#zepbound
#health
Everyday cooking
fromwww.independent.ie
2 months ago

Eilis O'Hanlon on The Skinny Jab Revolution: Is replacing the pleasure that food can bring with the joyless asceticism of drugs really the only solution?'

Kathryn Thomas's documentary critically examines the implications of weight-loss drugs, emphasizing the balance of convenience against long-term health effects.
UK news
fromIndependent
2 months ago

'In the States, they're injecting 12-year-olds. That isn't here yet, but it's on the way' - Kathryn Thomas on her weight-loss drugs documentary

Weight-loss drugs are easily obtainable, but caution is advised due to personal and ethical concerns.
Everyday cooking
fromwww.independent.ie
2 months ago

Eilis O'Hanlon on The Skinny Jab Revolution: Is replacing the pleasure that food can bring with the joyless asceticism of drugs really the only solution?'

Kathryn Thomas's documentary critically examines the implications of weight-loss drugs, emphasizing the balance of convenience against long-term health effects.
UK news
fromIndependent
2 months ago

'In the States, they're injecting 12-year-olds. That isn't here yet, but it's on the way' - Kathryn Thomas on her weight-loss drugs documentary

Weight-loss drugs are easily obtainable, but caution is advised due to personal and ethical concerns.
more#health
#glp-1
US news
fromWashington Post
2 months ago

Weight-loss drugs aren't just slimming waists. They're shifting the economy.

Weight-loss drugs are reshaping consumer habits and spending patterns, leading to a potential economic impact of billions.
Healthier weight-loss with GLP-1 drugs could boost GDP significantly.
US news
fromWashington Post
2 months ago

Weight-loss drugs aren't just slimming waists. They're shifting the economy.

Weight-loss drugs are reshaping consumer habits and spending patterns, leading to a potential economic impact of billions.
Healthier weight-loss with GLP-1 drugs could boost GDP significantly.
more#glp-1
#healthcare-policy
more#healthcare-policy
#obesity
Miscellaneous
fromTNW | Ecosystems
4 months ago

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

Verdiva has raised $410 million to develop oral drugs for obesity, challenging established players by addressing unmet medical needs in weight loss.
Miscellaneous
fromTNW | Ecosystems
4 months ago

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

Verdiva has raised $410 million to develop oral drugs for obesity, challenging established players by addressing unmet medical needs in weight loss.
more#obesity
fromWashington Post
5 months ago

Could Ozempic treat addiction?

Christensen's experience illustrated a notable side effect of GLP-1 agonists where, alongside losing weight, his previous cravings for drugs and alcohol significantly diminished, making his journey to recovery smoother.
Health
[ Load more ]